HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nagendra, S. N. Articles by Schloss, J. V. Search for Related Content PubMed PubMed Citation Articles by Nagendra, S. N. Articles by Schloss, J. V. Social Bookmarking                      What's this?

Volume 272, Number 39, Issue of September 26, 1997 pp. 24247-24251
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Carbamoylation of Brain Glutamate Receptors by a Disulfiram Metabolite

(Received for publication, May 22, 1997)

S. Ningaraj Nagendra , Morris D. Faiman , Kathleen Davis ^¶ , Jang-Yen Wu ^¶ , Xiangyue Newby and John V. Schloss

From the  Department of Pharmacology and Toxicology, the ^¶ Department of Physiology and Cell Biology, and the  Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66045

S-Methyl-N,N-diethylthiolcarbamate sulfoxide (DETC-MeSO), a metabolite of the drug disulfiram, is a selective carbamoylating agent for sulfhydryl groups. Treatment of glutamate receptors isolated from mouse brain with DETC-MeSO blocks glutamate binding. In vivo, carbamoylated glutathione, administered directly to mice or formed by reaction of DETC-MeSO with glutathione in the blood, also blocks brain glutamate receptors. Carbamoyl groups appear to be delivered to brain glutamate receptors or to liver aldehyde dehydrogenase in vivo by a novel glutathione-mediated mechanism. Seizures caused by the glutamate analogs N-methyl-D-aspartate and methionine sulfoximine, or by hyperbaric oxygen, are prevented by DETC-MeSO, indicating that carbamoylation of glutamate receptors gives an antagonist effect. These observations offer an explanation for some of the previously reported neurological effects of disulfiram, such as its ability to prevent O₂-induced seizures. Furthermore, some of the physiology of the disulfiram-ethanol reaction, that could not be accounted for based on the known inhibition of aldehyde dehydrogenase alone, may be explained by disulfiram's effect on glutamate receptors.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. M. LoPachin and D. S. Barber Synaptic Cysteine Sulfhydryl Groups as Targets of Electrophilic Neurotoxicants Toxicol. Sci., December 1, 2006; 94(2): 240 - 255. [Abstract] [Full Text] [PDF]

				W. J. Driscoll, S. A. Mueller, B. A. Eipper, and G. P. Mueller Differential Regulation of Peptide alpha -Amidation by Dexamethasone and Disulfiram Mol. Pharmacol., June 1, 1999; 55(6): 1067 - 1076. [Abstract] [Full Text]